Product Introduction:
Regain your confidence with ROGAINE® Men’s Foam 5% – the #1 dermatologist-recommended brand* for hair loss treatment. This clinically proven hair loss treatment reduces hair loss, revitalizes hair follicles, and regrows hair. The active ingredient, minoxidil, reactivates the hair growth cycle, stimulates regrowth, and reverses the progression of hereditary hair loss on the top of the scalp. ROGAINE® Men’s Foam 5% goes on easily and dries quickly, making it a convenient addition to your daily routine.
Features:
| Clinically Proven | Reduces hair loss, revitalizes hair follicles, and regrows hair |
| Active Ingredient | Minoxidil reactivates the hair growth cycle, stimulates regrowth, and reverses the progression of hereditary hair loss on the top of the scalp |
| Convenient | ROGAINE® Men’s Foam 5% goes on easily and dries quickly, making it a convenient addition to your daily routine |
| Visible Results | Results are visible after as little as four months of twice daily use |
| Three-Month Supply | One package contains a three-month supply |
Instructions:
For men 18-65 years, apply one-half capful (equivalent to 1 gram of foam) twice a day to the scalp in the hair loss area. Do not exceed two doses of one-half capful (equivalent to 2 grams of foam) within 24 hours. Massage into scalp with fingers, then wash hands thoroughly. Avoid contact with eyes or area of the body other than scalp. In case of accidental contact, rinse with a large amount of water. Avoid wetting scalp or activities leading to excessive sweating of the scalp for four hours. Using more or more often will not improve results. Continued use is necessary to increase and keep your hair regrowth or hair loss will begin again.
Ingredients:
Medicinal Ingredient: Minoxidil (5%). Non-Medicinal Ingredients: butylhydroxytoluene (BHT), cetyl alcohol, citric acid anhydrous, glycerol anhydrous, lactic acid, polysorbate 60, propellant Aeropin 70 (propane, butane, isobutane), purified water, SD alcohol 40B, stearyl alcohol.
*OTC hair loss treatment brand based on 2012 combined survey of Canada and USA.
